Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.38 |
| ▸ | LPL | P06858 | 6/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5788364 | 1.00 | LIPG (0.38) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL5503194 | 0.99 | LPL (0.37) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL29453590 | 0.89 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL29383962 | 0.89 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL5809203 | 0.89 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL29460237 | 0.89 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL374243 | 0.89 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL371497 | 0.89 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL28537539 | 0.89 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL766656 | 0.89 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160108317-A1 | DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND | MERCK PATENT GMBH (DE) | 2016-04-21 | — | — | US | disclosed |
| US-8816334-B2 | N-type materials and organic electronic devices | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2014-08-26 | — | — | US | disclosed |
| US-20120298976-A1 | N-Type Materials And Organic Electronic Devices | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-11-29 | — | — | US | disclosed |
| WO-2011049531-A1 | N-TYPE MATERIALS AND ORGANIC ELECTRONIC DEVICES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-04-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160108317-A1 | DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND | CRY1, SLC25A1, CRY2 | LIPG 3487/4885LPL 3274/4885TRPV1 614/4885 |
| US-20120298976-A1 | N-Type Materials And Organic Electronic Devices | NANS, DPAGT1, PNN | LIPG 2823/4885LPL 3702/4885TRPV1 1311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.